Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Yanlurukang capsules registry study in women with mammary gland hyperplasia and kidney Yang deficiency syndrome
ChiCTR-OPh-17011932Phase 4Recruiting
- Sponsor
- Third Affiliated Hospital, Beijing University of Chinese Medicine
- Start
- May 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of Yanlu Rukang in breast hyperplasia, sponsored by Third Affiliated Hospital, Beijing University of Chinese Medicine. Primary endpoint: Change of TCM symptoms. Started May 2017; status: recruiting.
02
Drugs
Yanlu Rukang
03
Conditions
breast hyperplasia
Beyond the preview
Go deeper on ChiCTR-OPh-17011932.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-OPh-17011932.